These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins. Stockwell BR; Schreiber SL Chem Biol; 1998 Jul; 5(7):385-95. PubMed ID: 9662508 [TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes. Luckett-Chastain LR; Cottrell ML; Kawar BM; Ihnat MA; Gallucci RM Exp Dermatol; 2017 Aug; 26(8):697-704. PubMed ID: 27892604 [TBL] [Abstract][Full Text] [Related]
10. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Rosado E; Schwartz Z; Sylvia VL; Dean DD; Boyan BD Biochim Biophys Acta; 2002 Jun; 1590(1-3):1-15. PubMed ID: 12063164 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809 [TBL] [Abstract][Full Text] [Related]
14. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. Kaneda T; Nojima T; Nakagawa M; Ogasawara A; Kaneko H; Sato T; Mano H; Kumegawa M; Hakeda Y J Immunol; 2000 Oct; 165(8):4254-63. PubMed ID: 11035059 [TBL] [Abstract][Full Text] [Related]
15. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6. Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342 [TBL] [Abstract][Full Text] [Related]